We Think You Can Look Beyond Cigna Group's (NYSE:CI) Lackluster Earnings
We Think You Can Look Beyond Cigna Group's (NYSE:CI) Lackluster Earnings
Soft earnings didn't appear to concern The Cigna Group's (NYSE:CI) shareholders over the last week. We did some digging, and we believe the earnings are stronger than they seem.
軟性收益似乎並未讓信諾集團(NYSE:CI)的股東在上週感到擔憂。我們進行了一些調查,我們相信收益比它們表現出來的更強。
The Impact Of Unusual Items On Profit
除了稀釋之外,還應該注意的是,萬集科技在過去12個月中因不尋常項目獲得了價值人民幣3.5萬元的利潤。雖然我們希望看到利潤增加,但當這些不尋常項目對利潤做出重大貢獻時,我們會更加謹慎。我們對全球大部分上市公司的數據進行了分析,發現不尋常項目往往是一次性的。這正如我們所期望的那樣,因爲這些提升被描述爲"不尋常"。相對於其利潤而言,萬集科技在2021年12月前的不尋常項目貢獻大。因此,我們可以推斷出,這些不尋常項目正在使其財務利潤顯著增強。
To properly understand Cigna Group's profit results, we need to consider the US$2.0b expense attributed to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. If Cigna Group doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.
要正確理解信諾集團的利潤結果,我們需要考慮到20億美元的飛凡項目費用。雖然由於飛凡項目而導致的扣除在第一時間令人失望,但事實上也有一線光明。我們查看了成千上萬家上市公司,發現非常多的飛凡項目通常是一次性的。而且,畢竟,這正是會計術語所暗示的。如果信諾集團沒有再次出現這些飛凡開支,那麼其他因素保持不變的情況下,我們預計它的利潤將在未來一年內增加。
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
這可能會讓您想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看基於其估計的未來盈利能力的互動圖表。
Our Take On Cigna Group's Profit Performance
我們對信諾集團的盈利表現的看法
Unusual items (expenses) detracted from Cigna Group's earnings over the last year, but we might see an improvement next year. Based on this observation, we consider it likely that Cigna Group's statutory profit actually understates its earnings potential! On the other hand, its EPS actually shrunk in the last twelve months. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. With this in mind, we wouldn't consider investing in a stock unless we had a thorough understanding of the risks. To help with this, we've discovered 3 warning signs (1 is a bit concerning!) that you ought to be aware of before buying any shares in Cigna Group.
飛凡項目(費用)在過去一年中影響了信諾集團的收入,但我們可能會在明年看到改善。根據這一觀察,我們認爲信諾集團的法定利潤實際上低估了其盈利潛力!另一方面,過去十二個月其每股收益實際上有所縮水。本文的目標是評估我們是否可以依賴法定收入來反映公司的潛力,但還有很多要考慮的因素。考慮到這一點,除非我們對風險有透徹的了解,否則我們不會考慮投資股票。爲了幫助理解,我們發現了3個警告信號(其中1個令人有些擔憂!),您在購買信諾集團的股票之前應該注意。
This note has only looked at a single factor that sheds light on the nature of Cigna Group's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
本筆記錄僅關注了一個揭示信諾集團利潤性質的因素。但如果您能專注於細節,總能發現更多。例如,許多人認爲高股本回報是有利可圖的商業經濟指標,而其他人喜歡「跟着資金走」,尋找內部人員在買入的股票。雖然這可能需要您進行一些研究,但您可能會發現這些公司的高股本回報收藏集,或者具有重要內部持股的股票列表會對您有所幫助。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接與我們聯繫。或者,發送電子郵件至editorial-team @ simplywallst.com。
Simply Wall St的這篇文章是一般性質的。我們僅基於歷史數據和分析師預測提供評論,使用公正的方法,我們的文章並非意在提供財務建議。這並不構成買入或賣出任何股票的建議,並且不考慮您的目標或財務狀況。我們旨在爲您帶來基於基礎數據驅動的長期聚焦分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St對提及的任何股票都沒有持倉。
譯文內容由第三人軟體翻譯。